surmount-1 trial tirzepatide obesity without diabetes Gastrointestinal tolerability and weight reduction associated with in adults with or overweight with and type 2 in the SURMOUNT‐1 to ‐4 trials - Rubino - 2025 Effect of tirzepatide in SURMOUNT-1

The role of periosteum in cartilage repair

For tirzepatide users specifically, understanding peptide-related hair loss provides additional context about the mechanisms involved

GLP-1 medications support weight loss by reducing cravings and quieting food noise

The glutathione system of peroxide detoxification is less efficient in neurons than in astroglial cells

While Novo is working on oral Wegovy that has shown remarkable weight loss benefits in trials, Pfizer has shared positive results for oral danuglipron

However, the history, clinical progression and radiographic appearance were not consistent with this diagnosis and, therefore, biopsy was indicated